Cargando…
Elevated C-Reactive Protein Levels and Enhanced High Frequency Vasomotion in Patients with Ischemic Heart Disease during Brachial Flow-Mediated Dilation
PURPOSE: The physiological role of vasomotion, rhythmic oscillations in vascular tone or diameter, and its underlying mechanisms are unknown. We investigated the characteristics of brachial artery vasomotion in patients with ischemic heart disease (IHD). METHODS: We performed a retrospective study o...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192359/ https://www.ncbi.nlm.nih.gov/pubmed/25299643 http://dx.doi.org/10.1371/journal.pone.0110013 |
_version_ | 1782338767613329408 |
---|---|
author | Watanabe, Shogo Amiya, Eisuke Watanabe, Masafumi Takata, Munenori Ozeki, Atsuko Watanabe, Aya Kawarasaki, Shuichi Nakao, Tomoko Hosoya, Yumiko Nagata, Kohzo Nagai, Ryozo Komuro, Issei |
author_facet | Watanabe, Shogo Amiya, Eisuke Watanabe, Masafumi Takata, Munenori Ozeki, Atsuko Watanabe, Aya Kawarasaki, Shuichi Nakao, Tomoko Hosoya, Yumiko Nagata, Kohzo Nagai, Ryozo Komuro, Issei |
author_sort | Watanabe, Shogo |
collection | PubMed |
description | PURPOSE: The physiological role of vasomotion, rhythmic oscillations in vascular tone or diameter, and its underlying mechanisms are unknown. We investigated the characteristics of brachial artery vasomotion in patients with ischemic heart disease (IHD). METHODS: We performed a retrospective study of 37 patients with IHD. Endothelial function was assessed using flow-mediated dilation (FMD), and power spectral analysis of brachial artery diameter oscillations during FMD was performed. Frequency-domain components were calculated by integrating the power spectrums in three frequency bands (in ms(2)) using the MemCalc (GMS, Tokyo, Japan): very-low frequency (VLF), 0.003–0.04 Hz; low frequency (LF), 0.04–0.15 Hz; and high frequency (HF), 0.15–0.4 Hz. Total spectral power (TP) was calculated as the sum of all frequency bands, and each spectral component was normalized against TP. RESULTS: Data revealed that HF/TP closely correlated with FMD (r = −0.33, p = 0.04), whereas VLF/TP and LF/TP did not. We also explored the relationship between elevated C-reactive protein (CRP) levels and vasomotion. HF/TP was significantly increased in subjects with high CRP levels (CRP;>0.08 mg/dL) compared with subjects with low CRP levels (0.052±0.026 versus 0.035±0.022, p<0.05). The HF/TP value closely correlated with CRP (r = 0.24, p = 0.04), whereas the value of FMD did not (r = 0.023, p = 0.84). In addition, elevated CRP levels significantly increased the value of HF/TP after adjustment for FMD and blood pressure (β = 0.33, p<0.05). CONCLUSION: The HF component of brachial artery diameter oscillation during FMD measurement correlated well with FMD and increased in the presence of elevated CRP levels in subjects with IHD. |
format | Online Article Text |
id | pubmed-4192359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41923592014-10-14 Elevated C-Reactive Protein Levels and Enhanced High Frequency Vasomotion in Patients with Ischemic Heart Disease during Brachial Flow-Mediated Dilation Watanabe, Shogo Amiya, Eisuke Watanabe, Masafumi Takata, Munenori Ozeki, Atsuko Watanabe, Aya Kawarasaki, Shuichi Nakao, Tomoko Hosoya, Yumiko Nagata, Kohzo Nagai, Ryozo Komuro, Issei PLoS One Research Article PURPOSE: The physiological role of vasomotion, rhythmic oscillations in vascular tone or diameter, and its underlying mechanisms are unknown. We investigated the characteristics of brachial artery vasomotion in patients with ischemic heart disease (IHD). METHODS: We performed a retrospective study of 37 patients with IHD. Endothelial function was assessed using flow-mediated dilation (FMD), and power spectral analysis of brachial artery diameter oscillations during FMD was performed. Frequency-domain components were calculated by integrating the power spectrums in three frequency bands (in ms(2)) using the MemCalc (GMS, Tokyo, Japan): very-low frequency (VLF), 0.003–0.04 Hz; low frequency (LF), 0.04–0.15 Hz; and high frequency (HF), 0.15–0.4 Hz. Total spectral power (TP) was calculated as the sum of all frequency bands, and each spectral component was normalized against TP. RESULTS: Data revealed that HF/TP closely correlated with FMD (r = −0.33, p = 0.04), whereas VLF/TP and LF/TP did not. We also explored the relationship between elevated C-reactive protein (CRP) levels and vasomotion. HF/TP was significantly increased in subjects with high CRP levels (CRP;>0.08 mg/dL) compared with subjects with low CRP levels (0.052±0.026 versus 0.035±0.022, p<0.05). The HF/TP value closely correlated with CRP (r = 0.24, p = 0.04), whereas the value of FMD did not (r = 0.023, p = 0.84). In addition, elevated CRP levels significantly increased the value of HF/TP after adjustment for FMD and blood pressure (β = 0.33, p<0.05). CONCLUSION: The HF component of brachial artery diameter oscillation during FMD measurement correlated well with FMD and increased in the presence of elevated CRP levels in subjects with IHD. Public Library of Science 2014-10-09 /pmc/articles/PMC4192359/ /pubmed/25299643 http://dx.doi.org/10.1371/journal.pone.0110013 Text en © 2014 Watanabe et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Watanabe, Shogo Amiya, Eisuke Watanabe, Masafumi Takata, Munenori Ozeki, Atsuko Watanabe, Aya Kawarasaki, Shuichi Nakao, Tomoko Hosoya, Yumiko Nagata, Kohzo Nagai, Ryozo Komuro, Issei Elevated C-Reactive Protein Levels and Enhanced High Frequency Vasomotion in Patients with Ischemic Heart Disease during Brachial Flow-Mediated Dilation |
title | Elevated C-Reactive Protein Levels and Enhanced High Frequency Vasomotion in Patients with Ischemic Heart Disease during Brachial Flow-Mediated Dilation |
title_full | Elevated C-Reactive Protein Levels and Enhanced High Frequency Vasomotion in Patients with Ischemic Heart Disease during Brachial Flow-Mediated Dilation |
title_fullStr | Elevated C-Reactive Protein Levels and Enhanced High Frequency Vasomotion in Patients with Ischemic Heart Disease during Brachial Flow-Mediated Dilation |
title_full_unstemmed | Elevated C-Reactive Protein Levels and Enhanced High Frequency Vasomotion in Patients with Ischemic Heart Disease during Brachial Flow-Mediated Dilation |
title_short | Elevated C-Reactive Protein Levels and Enhanced High Frequency Vasomotion in Patients with Ischemic Heart Disease during Brachial Flow-Mediated Dilation |
title_sort | elevated c-reactive protein levels and enhanced high frequency vasomotion in patients with ischemic heart disease during brachial flow-mediated dilation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192359/ https://www.ncbi.nlm.nih.gov/pubmed/25299643 http://dx.doi.org/10.1371/journal.pone.0110013 |
work_keys_str_mv | AT watanabeshogo elevatedcreactiveproteinlevelsandenhancedhighfrequencyvasomotioninpatientswithischemicheartdiseaseduringbrachialflowmediateddilation AT amiyaeisuke elevatedcreactiveproteinlevelsandenhancedhighfrequencyvasomotioninpatientswithischemicheartdiseaseduringbrachialflowmediateddilation AT watanabemasafumi elevatedcreactiveproteinlevelsandenhancedhighfrequencyvasomotioninpatientswithischemicheartdiseaseduringbrachialflowmediateddilation AT takatamunenori elevatedcreactiveproteinlevelsandenhancedhighfrequencyvasomotioninpatientswithischemicheartdiseaseduringbrachialflowmediateddilation AT ozekiatsuko elevatedcreactiveproteinlevelsandenhancedhighfrequencyvasomotioninpatientswithischemicheartdiseaseduringbrachialflowmediateddilation AT watanabeaya elevatedcreactiveproteinlevelsandenhancedhighfrequencyvasomotioninpatientswithischemicheartdiseaseduringbrachialflowmediateddilation AT kawarasakishuichi elevatedcreactiveproteinlevelsandenhancedhighfrequencyvasomotioninpatientswithischemicheartdiseaseduringbrachialflowmediateddilation AT nakaotomoko elevatedcreactiveproteinlevelsandenhancedhighfrequencyvasomotioninpatientswithischemicheartdiseaseduringbrachialflowmediateddilation AT hosoyayumiko elevatedcreactiveproteinlevelsandenhancedhighfrequencyvasomotioninpatientswithischemicheartdiseaseduringbrachialflowmediateddilation AT nagatakohzo elevatedcreactiveproteinlevelsandenhancedhighfrequencyvasomotioninpatientswithischemicheartdiseaseduringbrachialflowmediateddilation AT nagairyozo elevatedcreactiveproteinlevelsandenhancedhighfrequencyvasomotioninpatientswithischemicheartdiseaseduringbrachialflowmediateddilation AT komuroissei elevatedcreactiveproteinlevelsandenhancedhighfrequencyvasomotioninpatientswithischemicheartdiseaseduringbrachialflowmediateddilation |